151 related articles for article (PubMed ID: 15572213)
1. Molecular pathogenesis of Philadelphia chromosome negative myeloproliferative disorders.
Kralovics R; Skoda RC
Blood Rev; 2005 Jan; 19(1):1-13. PubMed ID: 15572213
[TBL] [Abstract][Full Text] [Related]
2. Comparison of molecular markers in a cohort of patients with chronic myeloproliferative disorders.
Kralovics R; Buser AS; Teo SS; Coers J; Tichelli A; van der Maas AP; Skoda RC
Blood; 2003 Sep; 102(5):1869-71. PubMed ID: 12730106
[TBL] [Abstract][Full Text] [Related]
3. Detection of abnormalities of PRV-1, TPO, and c-MPL genes detected by fluorescence in situ hybridization in essential thrombocythemia.
Puigdecanet E; Espinet B; Villa O; Florensa L; Besses C; Serrano S; Solé F
Cancer Genet Cytogenet; 2006 May; 167(1):39-42. PubMed ID: 16682284
[TBL] [Abstract][Full Text] [Related]
4. The chronic myeloproliferative disorders: clonality and clinical heterogeneity.
Spivak JL
Semin Hematol; 2004 Apr; 41(2 Suppl 3):1-5. PubMed ID: 15190515
[TBL] [Abstract][Full Text] [Related]
5. [New molecular markers within the chronic myeloproliferative disorders. I: the PRV-1 gene].
Larsen TS; Pallisgaard N; Christensen JH; Gram-Hansen P; Kerndrup GB; Møller MB; Hasselbalch HC
Ugeskr Laeger; 2006 Sep; 168(39):3295-9. PubMed ID: 17032591
[TBL] [Abstract][Full Text] [Related]
6. Advances in the molecular characterization of Philadelphia-negative chronic myeloproliferative disorders.
Pikman Y; Levine RL
Curr Opin Oncol; 2007 Nov; 19(6):628-34. PubMed ID: 17906464
[TBL] [Abstract][Full Text] [Related]
7. Etiology of the myeloproliferative disorders: the role of thrombopoietin.
Kaushansky K
Semin Hematol; 2003 Jan; 40(1 Suppl 1):6-9. PubMed ID: 12682875
[TBL] [Abstract][Full Text] [Related]
8. Expression of the GPI-anchored receptor Prv-1 enhances thrombopoietin and IL-3-induced proliferation in hematopoietic cell lines.
Dillon M; Minear J; Johnson J; Lannutti BJ
Leuk Res; 2008 May; 32(5):811-9. PubMed ID: 17980909
[TBL] [Abstract][Full Text] [Related]
9. Mpl Baltimore: a thrombopoietin receptor polymorphism associated with thrombocytosis.
Moliterno AR; Williams DM; Gutierrez-Alamillo LI; Salvatori R; Ingersoll RG; Spivak JL
Proc Natl Acad Sci U S A; 2004 Aug; 101(31):11444-7. PubMed ID: 15269348
[TBL] [Abstract][Full Text] [Related]
10. Hereditary thrombocytopenia due to reduced platelet production--report on two families and mutational screening of the thrombopoietin receptor gene (c-mpl).
Tonelli R; Strippoli P; Grossi A; Savoia A; Iolascon A; Savino M; Teriaca MS; Servedio V; Morfini M; Zelante L; Borgna-Pignatti C; Rosito P; Pession A; Paolucci G; Bagnara GP
Thromb Haemost; 2000 Jun; 83(6):931-6. PubMed ID: 10896251
[TBL] [Abstract][Full Text] [Related]
11. [Dysmegakaryocytopoiesis and dysthrombopoiesis in myeloproliferative syndromes].
Brière J; Kiladjian JJ; Peynaud-Debayle E
C R Seances Soc Biol Fil; 1996; 190(5-6):533-9. PubMed ID: 9074718
[TBL] [Abstract][Full Text] [Related]
12. JAK2 V617F mutation, PRV-1 overexpression and endogenous erythroid colony formation show different coexpression patterns among Ph-negative chronic myeloproliferative disorders.
Bellosillo B; Besses C; Florensa L; Solé F; Serrano S
Leukemia; 2006 Apr; 20(4):736-7. PubMed ID: 16453004
[No Abstract] [Full Text] [Related]
13. Elevated thrombopoietin levels and alterations in the sequence of its receptor, c-Mpl, in patients with Diamond-Blackfan anemia.
Pospisilova D; Cmejlova J; Slavik L; Cmejla R
Haematologica; 2004 Nov; 89(11):1391-2. PubMed ID: 15531462
[TBL] [Abstract][Full Text] [Related]
14. Towards a molecular understanding of polycythemia rubra vera.
Pahl HL
Eur J Biochem; 2000 Jun; 267(12):3395-401. PubMed ID: 10848954
[TBL] [Abstract][Full Text] [Related]
15. Lessons from familial myeloproliferative disorders.
Skoda R; Prchal JT
Semin Hematol; 2005 Oct; 42(4):266-73. PubMed ID: 16210040
[TBL] [Abstract][Full Text] [Related]
16. Molecular markers guide diagnosis and treatment in Philadelphia chromosome-negative myeloproliferative disorders (Review).
Vladareanu AM; Müller-Tidow C; Bumbea H; Radesi S
Oncol Rep; 2010 Mar; 23(3):595-604. PubMed ID: 20126996
[TBL] [Abstract][Full Text] [Related]
17. Normal thrombopoietin and its receptor (c-mpl) genes in children with essential thrombocythemia.
Randi ML; Putti MC; Pacquola E; Luzzatto G; Zanesco L; Fabris F
Pediatr Blood Cancer; 2005 Jan; 44(1):47-50. PubMed ID: 15390356
[TBL] [Abstract][Full Text] [Related]
18. Molecular markers for the diagnosis of Philadelphia chromosome negative myeloproliferative disorders.
Klippel S; Pahl HL
Pathol Biol (Paris); 2004 Jun; 52(5):267-74. PubMed ID: 15217712
[TBL] [Abstract][Full Text] [Related]
19. The genetic basis of myeloproliferative disorders.
Skoda R
Hematology Am Soc Hematol Educ Program; 2007; ():1-10. PubMed ID: 18024602
[TBL] [Abstract][Full Text] [Related]
20. The Jak2V617F mutation, PRV-1 overexpression, and EEC formation define a similar cohort of MPD patients.
Goerttler PS; Steimle C; März E; Johansson PL; Andreasson B; Griesshammer M; Gisslinger H; Heimpel H; Pahl HL
Blood; 2005 Oct; 106(8):2862-4. PubMed ID: 15985544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
